Annotation Detail for DCTN5

 Basic Information 
Top
        	
        			| Pathway ID | Pathway Name | 
|---|
| hsa04962 | Vasopressin-regulated water reabsorption | 
 
        	
        			| Desease Name | 
|---|
| bipolar disorder | 
| PSYCH | 
 
        	
        			| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication | 
|---|
| C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of DCTN5 mRNA | affects expression | 21346803 
 | 
| C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of DCTN5 mRNA | affects expression | 21346803 
 | 
| D016572 | Cyclosporine | Cyclosporine results in increased expression of DCTN5 mRNA | increases expression | 20106945 
 | 
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DCTN5 mRNA | affects binding|decreases expression|increases activity | 19710929 
 | 
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication | 
|---|
| MESH:D055371 | Acute Lung Injury |  | pirinixic acid | 3.58 | 18653653 | 
| MESH:D018248 | Adenoma, Liver Cell |  | pirinixic acid | 4.11 | 16434500 | 
| MESH:D001778 | Blood Coagulation Disorders |  | pirinixic acid | 3.57 | 19483382 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | 2,4-dinitrotoluene | 3.10 | 16705839 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | 2,6-dinitrotoluene | 3.10 | 16705839 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | 2,6-dinitrotoluene | 7.46 | 6135515 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | Cyclosporine | 7.46 | 12371664 | 
| MESH:D002779 | Cholestasis |  | Cyclosporine | 8.74 | 19486331 | 
| MESH:D002779 | Cholestasis |  | pirinixic acid | 8.74 | 19176532 | 
| MESH:D003490 | Cyanosis |  | 2,4-dinitrotoluene | 12.83 | 18551238 | 
| MESH:D003490 | Cyanosis |  | 2,6-dinitrotoluene | 12.83 | 18551238 | 
| MESH:D003876 | Dermatitis, Atopic |  | pirinixic acid | 2.57 | 18249437 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | 2,4-dinitrotoluene | 4.16 | 18551238	21346803 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | 2,6-dinitrotoluene | 4.16 | 18551238	21346803 | 
| MESH:D004487 | Edema |  | pirinixic acid | 2.90 | 12083418 | 
| MESH:D005234 | Fatty Liver |  | Cyclosporine | 9.01 | 19224547 | 
| MESH:D005234 | Fatty Liver |  | pirinixic acid | 9.01 | 19236843	20131406 | 
| MESH:D005355 | Fibrosis |  | Cyclosporine | 3.70 | 12639820	12168785 | 
| MESH:D005885 | Gingival Hyperplasia |  | Cyclosporine | 4.85 | 8708960 | 
| MESH:D006333 | Heart Failure |  | pirinixic acid | 2.76 | 20558911 | 
| MESH:D006457 | Hemoglobinuria, Paroxysmal |  | Cyclosporine | 5.05 | 15720958 | 
| MESH:D006529 | Hepatomegaly |  | pirinixic acid | 3.55 | 16221962	19772884	18467677	19176532 | 
| MESH:D006943 | Hyperglycemia |  | pirinixic acid | 3.58 | 20558911 | 
| MESH:D006973 | Hypertension |  | Cyclosporine | 2.21 | 10903974 | 
| MESH:D007333 | Insulin Resistance |  | pirinixic acid | 2.87 | 16306350 | 
| MESH:D007638 | Keratoconjunctivitis Sicca |  | Cyclosporine | 5.16 | 15604871 | 
| MESH:D007674 | Kidney Diseases |  | Cyclosporine | 2.54 | 8314463	18776723	10903974 | 
| MESH:D007680 | Kidney Neoplasms |  | 2,4-dinitrotoluene | 14.44 | 16705839 | 
| MESH:D007680 | Kidney Neoplasms |  | 2,6-dinitrotoluene | 14.44 | 16705839 | 
| MESH:D007680 | Kidney Neoplasms |  | Cyclosporine | 14.44 | 12371664 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | pirinixic acid | 1.35 | 15474484 | 
| MESH:D008113 | Liver Neoplasms |  | 2,6-dinitrotoluene | 4.81 | 7678174 | 
| MESH:D008113 | Liver Neoplasms |  | pirinixic acid | 4.81 | 16377806	15890375	20007298 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | 2,6-dinitrotoluene | 2.77 | 2876784	2876786	6135515 | 
| MESH:D008664 | Metal Metabolism, Inborn Errors |  | Cyclosporine | 5.51 | 16801185 | 
| MESH:D009135 | Muscular Diseases |  | pirinixic acid | 4.07 | 16239165 | 
| MESH:D009203 | Myocardial Infarction |  | pirinixic acid | 2.27 | 19151258 | 
| MESH:D015428 | Myocardial Reperfusion Injury |  | pirinixic acid | 3.25 | 16411023 | 
| MESH:D009336 | Necrosis |  | 2,4-dinitrotoluene | 12.54 | 18551238 | 
| MESH:D009336 | Necrosis |  | 2,6-dinitrotoluene | 12.54 | 7678174	18551238 | 
| MESH:D009369 | Neoplasms |  | pirinixic acid | 2.11 | 17405874 | 
| MESH:D009402 | Nephrosis, Lipoid |  | Cyclosporine | 5.16 | 17954296 | 
| MESH:D009404 | Nephrotic Syndrome |  | Cyclosporine | 3.65 | 18481113	19348381 | 
| MESH:D009765 | Obesity |  | pirinixic acid | 1.88 | 20558911 | 
| MESH:D009784 | Occupational Diseases |  | 2,4-dinitrotoluene | 10.23 | 12819281	16049721 | 
| MESH:D009784 | Occupational Diseases |  | 2,6-dinitrotoluene | 10.23 | 16049721 | 
| MESH:D011230 | Precancerous Conditions |  | Cyclosporine | 3.59 | 12371664 | 
| MESH:D011565 | Psoriasis |  | Cyclosporine | 2.33 | 16882103 | 
| MESH:D015427 | Reperfusion Injury |  | pirinixic acid | 2.55 | 19058328 | 
| MESH:D012640 | Seizures |  | 2,4-dinitrotoluene | 6.74 | 18551238 | 
| MESH:D012640 | Seizures |  | 2,6-dinitrotoluene | 6.74 | 18551238 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | 2,4-dinitrotoluene | 5.43 | 16049721 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | 2,6-dinitrotoluene | 5.43 | 16049721 | 
| MESH:D014571 | Urologic Neoplasms |  | 2,4-dinitrotoluene | 14.19 | 10091137 | 
| MESH:D014571 | Urologic Neoplasms |  | 2,6-dinitrotoluene | 14.19 | 10091137 | 
| MESH:D014605 | Uveitis |  | Cyclosporine | 4.71 | 1336536 | 
| MESH:D014985 | Xerophthalmia |  | Cyclosporine | 5.16 | 17120751 | 
| Pathway ID | Pathway Name | 
|---|
| KEGG:04962 | Vasopressin-regulated water reabsorption |